We are pleased to announce that the acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners has been completed. Read the Press Release
J.P. Morgan conferences bring together corporate leaders, financial sponsors and institutional investors to explore market and sector trends.
Advanced Therapies Week is an event that serves as a catalyst for pioneering progress, blending deep industry insights with cutting-edge technology in an environment that thrives on the energy of collaborative discovery. From igniting robust partnerships to sparking transformative ideas, Advanced Therapies Week is where the future of healthcare is shaped, making it the must-attend […]
Precision Medicine World Conference is promoting cross-functional fertilization and collaboration to accelerate precision medicine.
DCAT Week is the premier global event held annually in New York City for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain. It is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of […]
From early-stage up to commercial manufacturing, the scientific program allows attendees to gain actionable insights to enhance efficiency across all phases of biopharmaceutical development and production.
Division of Biochemical Technology of the American Chemical Society Annual Meeting
From groundbreaking presentations to dynamic panel discussions and expert-led roundtables, this event offers you invaluable insights into the challenges and opportunities across the gene therapy landscape. Whether it’s overcoming clinical trial complexities, navigating evolving regulatory requirements, or optimizing manufacturing scalability, this summit equips you with the knowledge needed to mitigate risks, avoid costly setbacks, and accelerate your gene […]
The American Biomanufacturing Summit is one of the most senior-level biomanufacturing conferences and networking events in the industry. Our executive biomanufacturing event is designed to provide biopharma executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics.
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO and Ampersand’s deep experience in CDMO investing to support Avid’s next stage of rapid growth including expanded offerings, talent investment and greater geographic reach London, UK, […]
Read moreAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and […]
Read moreTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that Avid stockholders voted to approve the transaction with […]
Read moreTUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, GHO Capital Partners LLP (“GHO”) and Ampersand Capital Partners (“Ampersand”) today announced they have entered into a definitive merger […]
Read moreTUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the upcoming Craig-Hallum Bioprocessing Conference. Nick Green, president and chief executive officer, and Pramthesh […]
Read moreTUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company has achieved a Committed Badge from EcoVadis, one of the world’s most trusted providers of […]
Read more© 2025 Avid Bioservices, Inc. All rights reserved.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
Notifications
